Xavier Llor MD
Advanced Endoscopic Interventional, Gastrointestinal Cancer
Co-Director, Cancer Genetics and Prevention Program Yale University
Join to View Full Profile
40 Temple StSte 1ANew Haven, CT 06510
Phone+1 203-785-4138
Fax+1 203-737-1345
Dr. Llor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Gastroenterology, 1994 - 1997
Advocate Health Care/Advocate Lutheran General HospitalResidency, Internal Medicine, 1991 - 1994
Autonomous University of Barcelona Faculty of MedicineClass of 1986
Certifications & Licensure
CT State Medical License 2013 - 2025
IL State Medical License 1991 - 2014
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Publications & Presentations
PubMed
- Electronic health record-based registry for identification of individuals at risk for hereditary cancer syndromes.Vinit Singh, Thomas E Rafter, Mohamad Sharbatji, Jing Liu, Quiana Brown
Journal of Medical Genetics. 2025-05-11 - Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer: Universal Germline vs Sequential Screening.Satoko Ito, Rosa M Xicola, Manraj Sra, Kunal C Potnis, Vinit Singh
Clinical Gastroenterology and Hepatology. 2025-04-30 - Advancing the Evaluation and Management of CDH1-Associated Gastric Cancer.Benjamin A Lerner, Samir Gupta, Carol A Burke, Sonia Kupfer, Bryson W Katona
Journal of the National Comprehensive Cancer Network. 2025-04-01
Press Mentions
Improving Cancer Outcomes with Better Lynch Syndrome Testing: A Cost-Benefit StudyJune 16th, 2025- ICYMI: Internal Medicine’s Most Popular Stories in 2024December 23rd, 2024
- Validation of the NCCN/Yale Criteria for the Identification of CDH1 Pathogenic Variant CarriersDecember 16th, 2024
- Join now to see all
Grant Support
- Epigenetic dysregulation in APC-negative colorectal cancerUNIVERSITY OF ARIZONA2020–2025
- Epigenetic dysregulation in APC-negative colorectal cancerUNIVERSITY OF ARIZONA2020–2025
- Epigenetic dysregulation in APC-negative colorectal cancerUNIVERSITY OF ARIZONA2020–2025
Committees
- Chair, Education and Training Committee. American Gastroenterological Association 2016 - Present
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
